Viridian Therapeutics, Inc.

NASDAQ:VRDN

19.67 (USD) • At close December 23, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012
Assets:
Current Assets:
Cash & Cash Equivalents 102.827155.57942.29945.89724.84632.60647.4413.34110.8325.1190.2090.113
Short Term Investments 374.543268.971154.66681.7421.99929.875000000
Cash and Short Term Investments 477.37424.55196.965127.63926.84562.48147.4413.34110.8325.1190.2090.113
Net Receivables 0.1020.1020.45100.1080.0241.4560.5240.3941.0880.9941.196
Inventory 0-6.623000000.0640.1870.1790.3570.17
Other Current Assets 9.0066.5212.6471.9725.385.234.8420.330.6420.3990.4950.186
Total Current Assets 486.478424.55200.163129.61129.73965.3751.8684.25911.7346.7852.0551.664
Non-Current Assets:
Property, Plant & Equipment, Net 3.3422.9362.0550.7870.5230.7270.5630.6251.1531.2140.9281.072
Goodwill 000000000000
Intangible Assets 000000000000
Goodwill and Intangible Assets 000000000000
Long Term Investments 000000000000
Tax Assets 000000000000
Other Non-Current Assets 0.6047.6051.4910.857-0.5230.050.050.2580.0150.090.690.046
Total Non-Current Assets 3.94610.5413.5461.6440.5230.7770.6130.8831.1681.3041.6181.117
Total Assets 490.424435.091203.709131.25530.26266.14752.4814.25912.9028.0893.6732.781
Liabilities & Equity:
Current Liabilities:
Account Payables 2.23914.2342.3290.671.0960.5710.9060.1590.2420.2550.10.027
Short Term Debt 0.8430.6130.520.4553.9762.294001.1050.080.69722.587
Tax Payables 00000000000.0760
Deferred Revenue 0.2880.2880.2890.3015.0083.78603.3771.01800.0760.788
Other Current Liabilities 23.26518.21410.4989.2485.1083.8682.9914.4261.1211.6540.5130.988
Total Current Liabilities 26.63533.34913.63610.67410.186.7333.8974.5852.4681.9891.38723.602
Non-Current Liabilities:
Long Term Debt 20.2054.645004.3288.0049.9222.820000.042
Deferred Revenue Non-Current 0.5730.8611.149000000000
Deferred Tax Liabilities Non-Current 000000000000
Other Non-Current Liabilities 0.9891.1721.2080.54400.0660.15200.0240.1090.2590.579
Total Non-Current Liabilities 21.7676.6782.3570.5444.3288.0710.0742.820.0240.1090.2590.621
Total Liabilities 48.40240.02715.99311.21814.50814.80313.9714.5852.4922.0981.64624.223
Equity:
Preferred Stock 206.516142.147133.833180.8010052.48176.97660.8536.05700
Common Stock 0.540.4140.2390.0420.3490.3080.2260.0070.1060.0380.0280
Retained Earnings -725.908-488.174-358.3-278.887-168.169-126.296-93.593-30.642-17.968-6.64-25.887-21.442
Accumulated Other Comprehensive Income/Loss 0.338-0.39-0.157-0.0080-0.003-2.835-0-0.739-0.555-0.411-0.263
Other Total Stockholders Equity 960.536741.067412.101218.089183.574177.335131.877-51.81428.27212.59328.2970.263
Total Shareholders Equity 442.022395.064187.716120.03715.75451.34438.51-0.32610.415.9912.027-21.442
Total Equity 442.022395.064187.716120.03715.75451.34438.51-0.32610.415.9912.027-21.442
Total Liabilities & Shareholders Equity 490.424435.091203.709131.25530.26266.14752.4814.25912.9028.0893.6732.781